9
Participants
Start Date
April 25, 2020
Primary Completion Date
August 31, 2020
Study Completion Date
September 30, 2020
Biological/Vaccine: Angiotensin peptide (1-7) derived plasma
angiotensin peptide (1-7) derived plasma will be given to COVID-19 positive participants
Kanuni Sultan Suleyman Training and Research Hospital, Istanbul
Kanuni Sultan Suleyman Training and Research Hospital
OTHER